A detailed history of Carmignac Gestion transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Carmignac Gestion holds 5,453 shares of MEDP stock, worth $2.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,453
Previous 8,680 37.18%
Holding current value
$2.19 Million
Previous $2.66 Million 17.18%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $919,275 - $1.33 Million
-3,227 Reduced 37.18%
5,453 $2.2 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $219,556 - $301,736
965 Added 12.51%
8,680 $2.66 Million
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $886,017 - $1.22 Million
5,083 Added 193.12%
7,715 $1.45 Million
Q4 2022

Feb 13, 2023

BUY
$153.06 - $226.57 $402,853 - $596,332
2,632 New
2,632 $559,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.